Clinical Trials

Clinical Trials

We have an unwavering commitment to improving care for patients with serious medical conditions through ongoing clinical development programs.

To learn more about clinical trials that are currently underway and to find out if a study is enrolling patients in your area or with your condition, please visit www.clinicaltrials.gov.

The results of certain applicable Jazz clinical trials are also available at www.clinicaltrials.gov.

As part of Jazz’s commitment to putting patients first, we are providing plain language summaries for certain clinical trials. These plain language summaries provide clinical trial results in an easy-to-understand format so all patients can obtain more information on the study results. Learn more about our study results.

Oncology

Study in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma

This is a Phase 2/3 Clinical Study evaluating the investigational medication JZP-458 for the treatment for pediatric and adult patients with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases. For more information, and to find out if a site is enrolling patients near you, please contact JZP458201@jazzpharma.com.

Study in Prevention of VOD

HarmonyThe HARMONY Phase 3 Clinical Study is evaluating an investigational medication for the prevention of hepatic veno-occlusive disease (VOD) in patients undergoing hematopoietic stem cell transplant. For more information, and to find out if a site is enrolling patients near you, please contact HarmonyTrialInfo@jazzpharma.com.

Study in Prevention of aGvHD

There is a Phase 2 Clinical Study evaluating an investigational medication for the prevention of acute graft-versus-host- disease (aGvHD) in adult and pediatric patients after allogeneic hematopoietic stem cell transplant. For more information, and to find out if a site is enrolling patients near you, please contact PreventionofaGvHDTrial@jazzpharma.com.

Neuroscience

Study of the Efficacy and Safety of JZP-258 in Subjects With Idiopathic Hypersomnia

This is a Phase 3 Clinical Study evaluating an investigational medication for the treatment of idiopathic hypersomnia. For more information, and to find out if a site is enrolling patients near you, please email customercare@jazzpharma.com or call 650-496-2951.